|
HSP90AB2P expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.083500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.356200E-03 |
| Normal-vs-Stage2 |
2.651800E-01 |
| Normal-vs-Stage3 |
1.077970E-02 |
| Normal-vs-Stage4 |
2.030200E-02 |
| Stage1-vs-Stage2 |
1.838990E-01 |
| Stage1-vs-Stage3 |
8.979200E-01 |
| Stage1-vs-Stage4 |
8.483800E-01 |
| Stage2-vs-Stage3 |
1.880790E-01 |
| Stage2-vs-Stage4 |
1.921570E-01 |
| Stage3-vs-Stage4 |
9.319000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.563600E-03 |
| Normal-vs-AfricanAmerican |
6.582200E-01 |
| Normal-vs-Asian |
3.138100E-02 |
| Caucasian-vs-AfricanAmerican |
6.458100E-03 |
| Caucasian-vs-Asian |
9.313400E-01 |
| AfricanAmerican-vs-Asian |
3.280300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.985600E-04 |
| Normal-vs-Female |
1.854270E-02 |
| Male-vs-Female |
2.675600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.585900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.082220E-02 |
| Normal-vs-Age(61-80Yrs) |
4.504300E-03 |
| Normal-vs-Age(81-100Yrs) |
4.46100000000005E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.581400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.509400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.224300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.118000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.859000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.446200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.028100E-02 |
| Classical-VS-Follicular |
1.362980E-04 |
| Classical-VS-Other |
2.447800E-01 |
| Classical-VS-Normal |
7.756000E-02 |
| Tall-VS-Follicular |
7.274800E-01 |
| Tall-VS-Other |
8.138400E-01 |
| Tall-VS-Normal |
2.703900E-03 |
| Follicular-VS-Other |
9.739800E-01 |
| Follicular-VS-Normal |
1.648690E-04 |
| Other-VS-Normal |
8.478100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.297200E-03 |
| Normal-vs-N1 |
3.355000E-03 |
| N0-vs-N1 |
4.491000E-01 |
|
|
